Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|July 9, 2008
Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastomaS V Picton, J Keeble, V Holden, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1982
Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in manP N Bennett, L J Aarons, M R Bending, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1997
Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the ratG E Blakey, I A Nestorov, P A Arundel, et al.British Journal of Cancer|February 25, 2010
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamideJ Bray, J Sludden, M J Griffin, et al.Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.Cancer Research|August 15, 1993
Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in childrenA V Boddy, S M Yule, R Wyllie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell linesX Lu, J Errington, V J Chen, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Comparison of continuous infusion and bolus administration of ifosfamide in childrenA V Boddy, S M Yule, R Wyllie, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administrationA V Boddy, S M Yule, R Wyllie, et al.Epilepsy Research|June 1, 1992
Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentolD D Shen, R H Levy, J L Savitch, et al.Pageof 9